Celgene (NASDAQ:CELG) reported Q4 2017 earnings this Morning, coming in at $1.80 per share, missing Wall Street’s estimates of $1.94 per Share. Revenue for the quarter came in at $3.48 billion beating analyst estimates of $3.46 billion Recent Insider Trading for Celgene (NASDAQ:CELG)
- On 9/25/2017 Terrie Curran, Insider, sold 1,727 with an average share price of $143.89 per share and the total transaction amounting to $248,498.03.
- On 9/12/2017 Gilla Kaplan, Director, sold 9,250 with an average share price of $141.56 per share and the total transaction amounting to $1,309,430.00.
- On 9/5/2017 Michael D Casey, Director, sold 9,250 with an average share price of $139.03 per share and the total transaction amounting to $1,286,027.50.
- On 8/10/2017 Ernest Mario, Director, sold 18,506 with an average share price of $130.52 per share and the total transaction amounting to $2,415,403.12.
- On 8/2/2017 Gilla Kaplan, Director, sold 7,500 with an average share price of $134.52 per share and the total transaction amounting to $1,008,900.00.
- On 6/26/2017 James J Loughlin, Director, sold 18,500 with an average share price of $133.57 per share and the total transaction amounting to $2,471,045.00.
Recent Trading for Celgene (NASDAQ:CELG) Shares of Celgene closed the previous trading session at 105.82 up +2.71 2.63% with shares trading hands.